Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection

Lipidomic profiling of plasma in patients with chronic hepatitis C infection

(2013) Feng Qu et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

A Serine Palmitoyltransferase Inhibitor Blocks Hepatitis C Virus Replication in Human Hepatocytes

(2013) Asao Katsume et al.   GASTROENTEROLOGY

Update on epidemiology of hepatitis B and C in China

(2013) Yan Cui et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide

(2012) Feng Qu et al.   PLoS One

Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy

(2011) Yoshito Itoh et al.   HEPATOLOGY RESEARCH

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy

(2010) Masayuki Kurosaki et al.   HEPATOLOGY RESEARCH

Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice

(2009) Nora Bijl et al.   HEPATOLOGY

Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice

(2009) Hongmei Zhao et al.   HEPATOLOGY

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection

(2009) T. J. S. Cross et al.   JOURNAL OF VIRAL HEPATITIS

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice

(2008) Gergana M. Deevska et al.   JOURNAL OF BIOLOGICAL CHEMISTRY